South Korea-based International Vaccine Institute (IVI) and the Pasteur Network have signed a landmark Memorandum of Understanding (MoU) to bolster their collaboration in global health initiatives. This agreement marks a significant step towards addressing infectious diseases and improving public health worldwide.

The MoU outlines a comprehensive framework for cooperation between the two organisations, focusing on several critical areas:

• Vaccine R&D Ecosystem: Strengthening vaccine research and development, particularly in the global South. This includes regional manufacturing of vaccines and enhancing public health responses to epidemic and pandemic emergencies.

• Training and Education: Supporting joint training and educational activities to build capacity and expertise in vaccine research and development.

• Collaborative Projects: Actively pursuing funding opportunities and developing joint proposals for research and training programs.

The partnership will be guided by a Steering Committee, ensuring regular reviews and progress on collaborative projects. Both parties have committed to clear communication, transparency, and adherence to policies on anti-fraud, corruption, equity, and sustainability.

This MOU represents a strategic alignment of resources and expertise, setting the stage for innovative solutions to global health challenges. Together, the Pasteur Network and IVI are poised to make a lasting impact on global health, particularly in regions that are most vulnerable to infectious diseases.

Image caption- Dr Jerome H. Kim, Director General of IVI, and Rebecca F. Grais, Executive Director of the Pasteur Network